| 摘要 |
It is provided a liquid preparation stably including (2S)-I- (4-amino-2, 3, 5-trimethylphenoxy) -3-{ 4-[ 4- (4-fluorobenzyl) phenyl] -1- piperazinyl} -2-propanol or its pharmaceutically acceptable salt as an active ingredient. The present invention relates to a liquid preparation including the above compound or its pharmaceutically acceptable salt as an active ingredient, the liquid preparation including: (a) at least one selected from the group consisting of sulfite, bisulfite, pyrosulfite, a-thioglycerol and cysteine, (b) a ß-cyclodextrin derivative, and (c) a pH buffer, wherein the pH value thereof is adjusted within a range of from 3 to 5. |
